The Online Investor
Horizon Therapeutics Plc (HZNP)

Horizon Therapeutics is focused on researching, developing and commercializing medicines that address needs for rare and rheumatic diseases. Co.'s segments are: Orphan, which includes Co.'s marketed medicines KRYSTEXXA® (pegloticase injection) for intravenous infusion, RAVICTI® (glycerol phenylbutyrate) oral liquid, PROCYSBI® (cysteamine bitartrate) delayed-release capsules for oral use, and ACTIMMUNE® (interferon gamma-1b) injection for subcutaneous use; and Inflammation, which includes Co.'s marketed medicines PENNSAID® (diclofenac sodium topical solution) 2% w/w, DUEXIS® (ibuprofen/famotidine) tablets, and VIMOVO® (naproxen/esomeprazole magnesium) delayed-release tablets, for oral use.

HZNP SEC Filing Email Alerts Service
Company Name: 
Horizon Therapeutics Plc
Drugs & Pharmaceuticals
Number of ETFs Holding HZNP: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
Quotes delayed 20 minutes

Email EnvelopeFree HZNP Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (3.94 out of 4)
71st percentile
(ranked higher than approx. 71% of all stocks covered)

Analysts' Target Price:
HZNP Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Horizon Therapeutics Plc (HZNP) Page | The Online Investor Page |

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.